Thermodynamics and Relative Solubility Prediction of Polymorphic Systems
This chapter contains sections titled: Introduction Methods Results and Discussion Example 25.1 Prediction of Ideal Solubility Ratio Between Forms II and I of Acemetacin at 293K Based on the Assumptions A, B, and C and Regression Equation 25.13 Application to an Estimation of Likely Impact on Drug S...
Saved in:
Published in | Chemical Engineering in the Pharmaceutical Industry p. 1 |
---|---|
Main Authors | , |
Format | Book Chapter |
Language | English |
Published |
Hoboken, NJ, USA
John Wiley & Sons
2011
John Wiley & Sons, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This chapter contains sections titled:
Introduction
Methods
Results and Discussion
Example 25.1 Prediction of Ideal Solubility Ratio Between Forms II and I of Acemetacin at 293K Based on the Assumptions A, B, and C and Regression Equation 25.13
Application to an Estimation of Likely Impact on Drug Solubility by Unknown More Stable Form
Example 25.2 Estimation of a Likely Impact on Solubility by a New Form of Ritonavir
Appendix
Conclusion
Appendix
Acknowledgments
References |
---|---|
AbstractList | This chapter contains sections titled:
Introduction
Methods
Results and Discussion
Example 25.1 Prediction of Ideal Solubility Ratio Between Forms II and I of Acemetacin at 293K Based on the Assumptions A, B, and C and Regression Equation 25.13
Application to an Estimation of Likely Impact on Drug Solubility by Unknown More Stable Form
Example 25.2 Estimation of a Likely Impact on Solubility by a New Form of Ritonavir
Appendix
Conclusion
Appendix
Acknowledgments
References |
Author | Ende David J. Am |
Author_xml | – sequence: 1 givenname: Yuriy A surname: Abramov fullname: Abramov, Yuriy A organization: Pfizer Global Research & Development, Pharmaceutical Sciences, Groton, CT, USA – sequence: 2 givenname: Klimentina surname: Pencheva fullname: Pencheva, Klimentina organization: Pfizer Global Research & Development, Pharmaceutical Sciences, Sandwich, Kent, UK |
BookMark | eNpVkD1PwzAQho0ACSj9A0wZWVrOl-8RVdAiVaKiBbFZdnxRTZy4ikNR_j1py8IN9_Xee8Nzwy4a1xBjdxymHAAf8jSDKIUsQ0Q-LbYYn7HxsOQxhjwKsxTOj_PhKMIkyfGKjb3_giFiSDDGa7bYbKmtne4bWZvCB7LRwRtZ2Zk9BWtnv5WxpuuDVUvaFJ1xTeDKYOVsX7t2tzVFsO59R7W_ZZeltJ7Gf3XE3p-fNrPFZPk6f5k9LicVj9J4kodUUpGjUrrUQ19CHsqUF3miOKisgBhlAoOsykgBqIRyxEyrFFBzkBiOWHj6-2Ms9YKUc5UXHMQBifiHRByQHNPguj-5qsbtyYpda2rZ9oModx21ouqA4-fsI8HwFwklZgY |
ContentType | Book Chapter |
Copyright | 2011 Copyright © 2011 John Wiley & Sons, Inc. |
Copyright_xml | – notice: 2011 – notice: Copyright © 2011 John Wiley & Sons, Inc. |
DOI | 10.1002/9780470882221.ch25 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISBN | 9781523143870 1523143878 0470882220 9780470882221 |
Editor | am Ende, David J |
Editor_xml | – sequence: 1 givenname: David J surname: am Ende fullname: am Ende, David J organization: Chemical R&D, Pfizer, Inc., Groton, CT, USA |
EndPage | 1 |
ExternalDocumentID | 10.1002/9780470882221.ch25 chapter_kt012XCV62 |
Genre | chapter |
GroupedDBID | 20A 38. 3VX 3W1 3X9 3XM 69Y AABBV AARDG AAUMZ ABQPW ADNCR ALMA_UNASSIGNED_HOLDINGS AZZ BBABE CMZ CSMTP CZZ IFKZM JFSCD JJU KIGQS KJBCJ KS6 KU6 LQKAK MYL TD3 UZ6 W1A YPLAZ ZEEST ABISH HZKEI IPJKO |
ID | FETCH-LOGICAL-k1475-93efec92bbdfd3eff093a71c96b10b8c052a602bbbf4b00b6e9228db702d10a23 |
IEDL.DBID | CMZ |
ISBN | 9780470426692 0470426691 |
IngestDate | Thu Jun 02 19:29:03 EDT 2022 Sat Nov 23 14:05:05 EST 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-k1475-93efec92bbdfd3eff093a71c96b10b8c052a602bbbf4b00b6e9228db702d10a23 |
PageCount | 1 |
ParticipantIDs | wiley_ebooks_10_1002_9780470882221_ch25_ch25 knovel_primary_chapter_kt012XCV62 |
PublicationCentury | 2000 |
PublicationDate | 2011 2010-11-29 |
PublicationDateYYYYMMDD | 2011-01-01 2010-11-29 |
PublicationDate_xml | – year: 2011 text: 2011 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken, NJ, USA |
PublicationPlace_xml | – name: Hoboken, NJ, USA |
PublicationTitle | Chemical Engineering in the Pharmaceutical Industry |
PublicationYear | 2011 2010 |
Publisher | John Wiley & Sons John Wiley & Sons, Inc |
Publisher_xml | – name: John Wiley & Sons – name: John Wiley & Sons, Inc |
SSID | ssj0000506252 |
Score | 1.438878 |
Snippet | This chapter contains sections titled:
Introduction
Methods
Results and Discussion
Example 25.1 Prediction of Ideal Solubility Ratio Between Forms II and I of... |
SourceID | wiley knovel |
SourceType | Publisher |
StartPage | 1 |
SubjectTerms | application to likely impact on drug solubility estimation ‐ and unknown, more stable form Chemistry & Chemical Engineering General References Pharmaceuticals Pharmaceuticals, Cosmetics & Toiletries qualification/quantification of impact ‐ of form change on drug absorption thermodynamics and relative solubility prediction ‐ of polymorphic systems |
TableOfContents | 25.1 Introduction
25.2 Methods
25.3 Results and Discussion
25.4 Application to an Estimation of Likely Impact on Drug Solubility by Unknown More Stable Form
25.5 Conclusion
25.A Appendix
25.B Appendix
Acknowledgments
References |
Title | Thermodynamics and Relative Solubility Prediction of Polymorphic Systems |
URI | https://app.knovel.com/hotlink/pdf/rcid:kpCEPIRDM1/id:kt012XCV62/chemical-engineering/thermodynamics-relative?kpromoter=Summon https://onlinelibrary.wiley.com/doi/abs/10.1002/9780470882221.ch25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwxV3Pb9MwFLamiQPiAAwQA4aMhHZqGttNnHgXDt2mAiqKRocqLlH8S5uyJdWaTeoO-1f4V_GzU6py4oYURbEjxfLLp_een_2-h9BHS7QwIqsiZ5xJlFhBI2cEdQRsZ849psz4YhPTb3xynnyZp_Md9LDOhYHiVnXT3pkrr6Yv2g42MuOFtjEUmT2qF-OT4vPZ8ZTG0Oqcfp2Pf3AWqz6_PjIbHr8YfKjrVofa7ssopIfcmU_1wp91c1gJsSZQ4URA5Yfx9OefEA1JiVsd-LVcksFagwu65uzp26zPw3F6Je77czC5dKguoPr2ozCXbc_Xm67Tp-jXetLhxEo9vO3kUN3_xQf5_6TyDD2BhAsMmRCu9znaMc0eOiwCp_ZqgGebFLHlAB_iYsO2vXqBJrOtcXDVaHzWj4Uh6OdP_65wcQNbUgBD3FpctFer69Zh7FLhnrT9JTo_PZmNJ1FfHiKqaZKlDlPGGiWYlNpq92yJGFUZVYJLSmSuSMoqTtxraROnXCQ3grFcy4wwTUnFRq_QbtM25jXC1nlRiutsJI1OHKjzzORMWZ6kytJUV_voQxB_uQgcIKUKMik3st5HA_-PS7_LvSwDHzQrt2BRAiz87c0_fPItehxC2HC9Q7vdza05cD5QJ997pLr71-_8N7k9DJw |
link.rule.ids | 779,780,784,793,2090,11353,27925 |
linkProvider | Knovel |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Chemical+Engineering+in+the+Pharmaceutical+Industry+-+R%26D+to+Manufacturing&rft.au=Ende+David+J.+Am&rft.atitle=Thermodynamics+and+Relative+Solubility+Prediction+of+Polymorphic+Systems&rft.date=2011-01-01&rft.pub=John+Wiley+%26+Sons&rft.isbn=9780470426692&rft.spage=1&rft.epage=1&rft_id=info:doi/10.1002%2F9780470882221.ch25&rft.externalDocID=chapter_kt012XCV62 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcontent.knovel.com%2Fcontent%2FThumbs%2Fthumb14053.gif |